Acelrx Pharmaceuticals Inc. buy tamam
Start price
23.10.18
/
50%
€70.72
Target price
23.04.19
€131.69
Performance (%)
-13.27%
End price
23.04.19
€61.34
Summary
This prediction ended on 23.04.19 with a price of €61.34. The price of Acelrx Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -14.050% | -14.050% | 201.449% | 39.410% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
(Laufzeit überschritten)
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€65.49
24.04.19
24.04.19
€117.26
04.11.21
04.11.21
-77.63%
05.11.21
05.11.21
